Suzanne E. Geerlings
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
Papers in
- Epidemiology 135
- Urinary Tract Infections Management 126
-
- HIV/AIDS Research and Interventions 38
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 11
- Infection Control in Healthcare 8
- Co-authors
- Andy I. M. Hoepelman (26 shared papers)Lindsay E. Nicolle (4 shared papers)Suzanne Bradley (4 shared papers)Sanjay K. Saint (3 shared papers)Thomas M. Hooton (3 shared papers)Anthony J. Schaeffer (3 shared papers)Richard Colgan (3 shared papers)Jan M. Prins (43 shared papers)
- Journals
- Clinical Infectious Diseases (18 papers)BMC Infectious Diseases (13 papers)PLoS ONE (12 papers)Clinical Microbiology and Infection (9 papers)Journal of Antimicrobial Chemotherapy (8 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Suzanne E. Geerlings
287 papers receiving 17k citations
Suzanne E. Geerlings's Hit Papers
Peers
Comparison fields: 5 of 162
- Applied Microbiology and Biotechnology 987
- Infectious Diseases 5k
- Epidemiology 5.1k
- Emergency Medicine 1.1k
- Immunology 1.7k
Countries citing papers authored by Suzanne E. Geerlings
This map shows the geographic impact of Suzanne E. Geerlings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Geerlings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Geerlings more than expected).
Fields of papers citing papers by Suzanne E. Geerlings
This network shows the impact of papers produced by Suzanne E. Geerlings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Geerlings. The network helps show where Suzanne E. Geerlings may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne E. Geerlings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1757 |
| 3 | Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America Hit paper breakdown → | 2010 | 1582 |
| 4 | Immune dysfunction in patients with diabetes mellitus (DM) Hit paper breakdown → | 1999 | 1012 |
| 5 | Future challenges for clinical care of an ageing population infected with HIV: a modelling study Hit paper breakdown → | 2015 | 711 |
| 6 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 7 | Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study Hit paper breakdown → | 2014 | 645 |
| 8 | Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa Hit paper breakdown → | 2019 | 584 |
| 9 | Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2018 | 356 |
| 10 | 2020 | 323 | |
| 11 | 2014 | 215 | |
| 12 | 2014 | 207 | |
| 13 | 2016 | 199 | |
| 14 | 2000 | 193 | |
| 15 | 2008 | 174 | |
| 16 | European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines Hit paper breakdown → | 2024 | 170 |
| 17 | 2013 | 152 | |
| 18 | 2017 | 151 | |
| 19 | 2015 | 145 | |
| 20 | 2022 | 145 |
About Suzanne E. Geerlings
Suzanne E. Geerlings is a scholar working on Epidemiology, Infectious Diseases, Applied Microbiology and Biotechnology, Emergency Medicine and Emergency Medical Services, having authored 308 papers that have together received 17.7k indexed citations. Recurring topics across this work include Urinary Tract Infections Management (126 papers), HIV/AIDS Research and Interventions (38 papers), Antibiotic Use and Resistance (33 papers), HIV-related health complications and treatments (11 papers), COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Hospital Admissions and Outcomes (9 papers) and Infection Control in Healthcare (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (987 citations), Infectious Diseases (5k citations), Epidemiology (5.1k citations), Emergency Medicine (1.1k citations) and Immunology (1.7k citations). Suzanne E. Geerlings has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Andy I. M. Hoepelman, Lindsay E. Nicolle, Suzanne Bradley, Sanjay K. Saint, Thomas M. Hooton, Anthony J. Schaeffer, Richard Colgan, Jan M. Prins, Peter Tenke A and Diana D. Cardenas. Their work appears in journals such as Clinical Infectious Diseases, BMC Infectious Diseases, PLoS ONE, Clinical Microbiology and Infection and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.